The phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the ...

DelveInsight's report on Alpha Thalassemia provides a comprehensive analysis of the epidemiology and <a target=_blank href= ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

Brandon High School’s community school is in its third year of supporting its students and their families by providing food ...

Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

In its 2024 opinion in Vanegas v. Signet Builders, Inc., the U.S. Court of Appeals for the Seventh Circuit joined a growing number of federal ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

Unusual total active option classes on open include: B2Gold ( BTG ), Verizon ( VZ ), Zscaler ( ZS ), American Express ( AXP ), Mastercard ( MA ), KE Holdings ( BEKE ), Novo Nordisk ( NVO ), Microchip ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

The new anti-DEI proposal was backed by a group called the National Center for Public Policy Research (NCPPR) and submitted ...

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...